Company Valuation: Supergenics

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 27.44 26.04 27.44 24.77 69.41 29.11
Change - -5.08% 5.36% -9.71% 180.21% -58.07%
Enterprise Value (EV) 1 29.58 29.55 32.12 26.86 73.89 32.5
Change - -0.1% 8.69% -16.38% 175.13% -56.01%
P/E -12.7x 1,284x 79.3x 123x -9.45x -8.61x
PBR 5.03x 4.76x 5.44x 2.85x 21x 250x
PEG - -13x 0x -2.5x 0x 0.2x
Capitalization / Revenue 5.34x 2.37x 2.56x 2.42x 13x 5.17x
EV / Revenue 5.76x 2.69x 3x 2.62x 13.9x 5.78x
EV / EBITDA -16.7x 26.7x 18.3x 12.5x -11.1x -14.4x
EV / EBIT -14.7x 63.9x 27.2x 17.5x -10x -10.5x
EV / FCF -15.7x -28.3x -38.7x -183x -54.1x 19.2x
FCF Yield -6.39% -3.54% -2.58% -0.55% -1.85% 5.21%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.0232 0.000218 0.003718 0.001876 -0.0635 -0.029
Distribution rate - - - - - -
Net sales 1 5.135 10.99 10.72 10.24 5.322 5.625
EBITDA 1 -1.769 1.107 1.752 2.148 -6.675 -2.264
EBIT 1 -2.013 0.4625 1.181 1.534 -7.357 -3.107
Net income 1 -2.15 0.0203 0.3458 0.1769 -7.281 -3.366
Net Debt 1 2.147 3.512 4.684 2.084 4.477 3.394
Reference price 2 0.2950 0.2800 0.2950 0.2300 0.6000 0.2500
Nbr of stocks (in thousands) 93,000 93,000 93,000 107,706 115,689 116,430
Announcement Date 4/30/21 4/29/22 4/28/23 4/30/24 4/30/25 4/30/26
1MYR in Million2MYR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 7.15M
34.53x6.07x18.77x0.95% 49.74B
-23.85x349.22x-22.56x-.--% 40.49B
47.3x4.68x29.91x-.--% 34.35B
25.34x2.8x12.11x-.--% 34.75B
27.63x7.94x19.87x0.41% 26.98B
32.22x5.2x23.7x-.--% 15.6B
-24.06x15.69x-23.46x-.--% 14.27B
23.93x2.04x8.96x1.12% 13.76B
Average 17.88x 49.20x 8.41x 0.31% 25.55B
Weighted average by Cap. 19.53x 66.31x 9.41x 0.32%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 03033 Stock
  4. Valuation Supergenics